BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7470196)

  • 21. Effects of probucol on homozygous cases of familial hypercholesterolemia.
    Yamamoto A; Matsuzawa Y; Kishino B; Hayashi R; Hirobe K; Kikkawa T
    Atherosclerosis; 1983 Aug; 48(2):157-66. PubMed ID: 6615580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma exchange treatment for severe familial hypercholesterolemia: a comparison of two different techniques.
    Dairou F; Rottembourg J; Truffert J; Assogba U; Bruckert E; de Gennes JL; Jacobs C
    Beitr Infusionsther; 1988; 23():152-9. PubMed ID: 2484771
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of combined LDL affinity apheresis utilizing dextran sulfate cellulose columns and hypolipidemic medications in patients with severe hypercholesterolemia to assess regression of atherosclerosis.
    Jones PH
    Beitr Infusionsther; 1988; 23():142-5. PubMed ID: 2484769
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of hypercholesterolemia.
    Kane JP; Havel RJ
    Annu Rev Med; 1986; 37():427-35. PubMed ID: 3518611
    [No Abstract]   [Full Text] [Related]  

  • 25. Pseudohomozygous type II hyperlipoproteinemia.
    Morganroth J; Levy RI; McMahon AE; Gotto AM
    J Pediatr; 1974 Nov; 85(5):639-43. PubMed ID: 4370845
    [No Abstract]   [Full Text] [Related]  

  • 26. Liver transplantation for treatment of cardiovascular disease: comparison with medication and plasma exchange in homozygous familial hypercholesterolemia.
    Hoeg JM; Starzl TE; Brewer HB
    Am J Cardiol; 1987 Mar; 59(6):705-7. PubMed ID: 3548303
    [No Abstract]   [Full Text] [Related]  

  • 27. Probucol (Lorelco) in treatment of hyperlipemia.
    Murphy BF
    JAMA; 1977 Dec; 238(23):2537-8. PubMed ID: 199758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholestyramine for elevated serum cholesterol.
    Med Lett Drugs Ther; 1974 Apr; 16(8):33-4. PubMed ID: 4362570
    [No Abstract]   [Full Text] [Related]  

  • 29. Familial type II hyperlipoproteinaemia. Clinical features and results of treatment in children and young adults.
    Stein EA; Mendelsohn D; Bersohn I
    S Afr Med J; 1974 Jan; 48(4):135-8. PubMed ID: 4363092
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparison of cholestyramine and nicotinic acid in the treatment of familial type II hyperlipoproteinaemia.
    Mann JI; Harding PA; Turner RC; Wilkinson RH
    Br J Clin Pharmacol; 1977 Jun; 4(3):305-8. PubMed ID: 197982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma exchange and LDL apheresis.
    Thompson GR; Okabayashi K
    Prog Clin Biol Res; 1988; 255():311-6. PubMed ID: 3277202
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of probucol on xanthomata regression in familial hypercholesterolemia.
    Yamamoto A; Matsuzawa Y; Yokoyama S; Funahashi T; Yamamura T; Kishino B
    Am J Cardiol; 1986 Jun; 57(16):29H-35H. PubMed ID: 3728307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis and management of lipoprotein disorders.
    Schaefer EJ; Levy RI
    N Engl J Med; 1985 May; 312(20):1300-10. PubMed ID: 3887163
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of probucol on the composition and in vitro catabolism of LDL in type IIa hypercholesterolemia.
    Baudet MF; Esteva O; Dachet C; Jacotot B
    Atherosclerosis; 1986 Oct; 62(1):65-71. PubMed ID: 3778575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
    Stein E; Kreisberg R; Miller V; Mantell G; Washington L; Shapiro DR
    Arch Intern Med; 1990 Feb; 150(2):341-5. PubMed ID: 2405804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lovastatin: cholesterol-lowering agent.
    DiPalma JR
    Am Fam Physician; 1987 Dec; 36(6):189-92. PubMed ID: 3687679
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of combined fenofibrate and cholestyramine therapy on low-density lipoprotein kinetics in familial hypercholesterolemia patients.
    Malmendier CL; Delcroix C; Lontie JF
    Clin Chim Acta; 1987 Jan; 162(2):221-7. PubMed ID: 3829426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experimental and clinical study of Vasosan P, a new form of pectin-enriched cholestyramine].
    Ryzhenkov VE; Chistiakova AM; Triufanov VF; Vasil'eva LE; Frolova IuV; Solov'eva MA; Remezova OV; Lozovskiĭ VT; Khanefel'd M; Leonkhardt V
    Kardiologiia; 1990 Aug; 30(8):77-9. PubMed ID: 2255152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sterol synthesis in vitro in freshly isolated blood mononuclear leukocytes from familial hypercholesterolemic patients treated with probucol.
    McNamara DJ; Bloch CA; Botha A; Mendelsohn D
    Biochim Biophys Acta; 1985 Mar; 833(3):412-6. PubMed ID: 3970963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma-exchange therapy of homozygous familial hypercholesterolemia.
    King ME; Breslow JL; Lees RS
    N Engl J Med; 1980 Jun; 302(26):1457-9. PubMed ID: 7374711
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.